Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxk1
|
ENSMUSG00000056493.8 | forkhead box K1 |
Foxj1
|
ENSMUSG00000034227.7 | forkhead box J1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_116337098_116337446 | Foxj1 | 1873 | 0.196201 | 0.19 | 1.5e-01 | Click! |
chr11_116331718_116331869 | Foxj1 | 3606 | 0.122884 | -0.17 | 2.0e-01 | Click! |
chr11_116334027_116335400 | Foxj1 | 686 | 0.518091 | 0.14 | 2.8e-01 | Click! |
chr11_116332063_116332902 | Foxj1 | 2917 | 0.138077 | -0.14 | 2.9e-01 | Click! |
chr11_116332941_116333686 | Foxj1 | 2086 | 0.176344 | 0.10 | 4.3e-01 | Click! |
chr5_142367067_142367336 | Foxk1 | 34296 | 0.181778 | 0.37 | 3.7e-03 | Click! |
chr5_142400416_142400717 | Foxk1 | 931 | 0.640784 | 0.32 | 1.2e-02 | Click! |
chr5_142424510_142425502 | Foxk1 | 23506 | 0.175736 | 0.31 | 1.8e-02 | Click! |
chr5_142372277_142372523 | Foxk1 | 29097 | 0.195137 | 0.29 | 2.6e-02 | Click! |
chr5_142401130_142401415 | Foxk1 | 225 | 0.948290 | 0.27 | 3.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_45445658_45446098 | 6.17 |
Btrc |
beta-transducin repeat containing protein |
370 |
0.86 |
chr17_40811481_40812037 | 5.66 |
Rhag |
Rhesus blood group-associated A glycoprotein |
575 |
0.7 |
chr1_112456627_112457016 | 5.51 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr10_99912846_99913873 | 5.21 |
Gm47579 |
predicted gene, 47579 |
47339 |
0.13 |
chrX_143825863_143827628 | 4.77 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr18_61663767_61665554 | 4.49 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
830 |
0.45 |
chr12_32208046_32209200 | 3.71 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
12 |
0.98 |
chr16_44015370_44016774 | 3.60 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr18_62176067_62177775 | 3.60 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr2_35334268_35334953 | 3.49 |
Stom |
stomatin |
2366 |
0.21 |
chr5_43869783_43870400 | 3.47 |
Cd38 |
CD38 antigen |
1231 |
0.3 |
chr8_121088119_121090419 | 3.47 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr6_67161907_67162479 | 3.18 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
2731 |
0.23 |
chr14_41007005_41008239 | 3.18 |
Prxl2a |
peroxiredoxin like 2A |
644 |
0.68 |
chr9_19622616_19622889 | 3.17 |
Zfp317 |
zinc finger protein 317 |
47 |
0.96 |
chr9_48338929_48340200 | 3.16 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr6_17515642_17516135 | 3.15 |
Met |
met proto-oncogene |
19113 |
0.22 |
chr7_120979495_120980366 | 3.05 |
Cdr2 |
cerebellar degeneration-related 2 |
1860 |
0.19 |
chr3_85195301_85195774 | 2.96 |
Gm38313 |
predicted gene, 38313 |
910 |
0.67 |
chr19_55925899_55926423 | 2.95 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
27852 |
0.21 |
chr5_119673827_119675890 | 2.94 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr10_115817324_115818606 | 2.85 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr6_146219888_146220144 | 2.85 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
7527 |
0.26 |
chr5_43515484_43516406 | 2.83 |
C1qtnf7 |
C1q and tumor necrosis factor related protein 7 |
183 |
0.94 |
chr4_115057577_115059724 | 2.80 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr1_136945385_136947968 | 2.79 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr6_4507701_4508122 | 2.79 |
Gm43921 |
predicted gene, 43921 |
1824 |
0.26 |
chr3_69041923_69042226 | 2.74 |
Trim59 |
tripartite motif-containing 59 |
2641 |
0.18 |
chr17_86536044_86537023 | 2.68 |
Gm10309 |
predicted gene 10309 |
31301 |
0.19 |
chr5_64810297_64813272 | 2.68 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr1_161766766_161767491 | 2.67 |
Gm5049 |
predicted gene 5049 |
21072 |
0.12 |
chr3_14890853_14891237 | 2.66 |
Car2 |
carbonic anhydrase 2 |
4406 |
0.22 |
chr12_78863892_78864556 | 2.62 |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
2094 |
0.25 |
chr15_32780266_32781493 | 2.60 |
Gm32618 |
predicted gene, 32618 |
1975 |
0.38 |
chr13_107100937_107101851 | 2.55 |
Gm31452 |
predicted gene, 31452 |
37699 |
0.14 |
chr16_92693730_92694957 | 2.55 |
Runx1 |
runt related transcription factor 1 |
1152 |
0.59 |
chr11_4031787_4032434 | 2.54 |
Sec14l4 |
SEC14-like lipid binding 4 |
268 |
0.85 |
chr14_67001080_67002197 | 2.52 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
1130 |
0.43 |
chr1_184729496_184731200 | 2.51 |
Hlx |
H2.0-like homeobox |
1250 |
0.37 |
chr6_67268890_67269439 | 2.51 |
Serbp1 |
serpine1 mRNA binding protein 1 |
1834 |
0.27 |
chr1_134801821_134802618 | 2.50 |
Gm37949 |
predicted gene, 37949 |
234 |
0.87 |
chr7_24903411_24904198 | 2.50 |
Arhgef1 |
Rho guanine nucleotide exchange factor (GEF) 1 |
552 |
0.57 |
chr15_6579077_6580099 | 2.48 |
Fyb |
FYN binding protein |
283 |
0.92 |
chr10_36311094_36311252 | 2.47 |
Gm47049 |
predicted gene, 47049 |
80419 |
0.11 |
chr14_75136350_75137361 | 2.47 |
Gm15628 |
predicted gene 15628 |
57 |
0.84 |
chr4_87805839_87806716 | 2.46 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
17 |
0.99 |
chr4_118544360_118544725 | 2.45 |
Tmem125 |
transmembrane protein 125 |
498 |
0.69 |
chr6_127034730_127034972 | 2.44 |
Fgf6 |
fibroblast growth factor 6 |
19265 |
0.11 |
chr9_21337624_21338958 | 2.44 |
Slc44a2 |
solute carrier family 44, member 2 |
463 |
0.67 |
chr7_97749255_97749938 | 2.43 |
Aqp11 |
aquaporin 11 |
11307 |
0.16 |
chr8_57513444_57513905 | 2.43 |
Hmgb2 |
high mobility group box 2 |
1126 |
0.33 |
chr3_14888603_14889051 | 2.41 |
Car2 |
carbonic anhydrase 2 |
2188 |
0.31 |
chr10_82991418_82991936 | 2.40 |
Chst11 |
carbohydrate sulfotransferase 11 |
6179 |
0.19 |
chr4_41272272_41273407 | 2.40 |
Ubap2 |
ubiquitin-associated protein 2 |
2277 |
0.18 |
chr9_75780120_75780587 | 2.39 |
Bmp5 |
bone morphogenetic protein 5 |
4989 |
0.23 |
chr14_120276275_120277139 | 2.31 |
Mbnl2 |
muscleblind like splicing factor 2 |
977 |
0.66 |
chr2_152850125_152850337 | 2.31 |
Tpx2 |
TPX2, microtubule-associated |
2149 |
0.21 |
chr9_22134719_22135019 | 2.30 |
Acp5 |
acid phosphatase 5, tartrate resistant |
822 |
0.35 |
chr12_99457193_99458078 | 2.30 |
Foxn3 |
forkhead box N3 |
7538 |
0.2 |
chr6_38553801_38553963 | 2.28 |
Luc7l2 |
LUC7-like 2 (S. cerevisiae) |
1841 |
0.28 |
chr4_128817721_128818315 | 2.27 |
Zfp362 |
zinc finger protein 362 |
11973 |
0.16 |
chr2_127131776_127132184 | 2.27 |
Ncaph |
non-SMC condensin I complex, subunit H |
1917 |
0.28 |
chr4_87804582_87805116 | 2.26 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
1445 |
0.57 |
chr12_34713492_34714861 | 2.25 |
Gm47357 |
predicted gene, 47357 |
85538 |
0.09 |
chr12_69757617_69759559 | 2.25 |
Mir681 |
microRNA 681 |
5356 |
0.14 |
chr8_56639071_56639580 | 2.24 |
Fbxo8 |
F-box protein 8 |
51405 |
0.12 |
chr7_141133085_141133457 | 2.24 |
Ptdss2 |
phosphatidylserine synthase 2 |
718 |
0.43 |
chr7_75613990_75614480 | 2.23 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
453 |
0.84 |
chr6_136857054_136858156 | 2.23 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr4_130914895_130915515 | 2.23 |
Laptm5 |
lysosomal-associated protein transmembrane 5 |
263 |
0.91 |
chr11_8502774_8504068 | 2.23 |
Tns3 |
tensin 3 |
34746 |
0.23 |
chr10_117146369_117146576 | 2.22 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
2023 |
0.25 |
chr11_87665269_87665714 | 2.22 |
Rnf43 |
ring finger protein 43 |
942 |
0.44 |
chr9_108287439_108287601 | 2.20 |
Nicn1 |
nicolin 1 |
2909 |
0.12 |
chr8_85379656_85380136 | 2.19 |
Mylk3 |
myosin light chain kinase 3 |
1082 |
0.42 |
chr6_57822563_57823744 | 2.19 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
1487 |
0.3 |
chr11_85833878_85836704 | 2.18 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr18_62174392_62175675 | 2.18 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr16_76323141_76323301 | 2.17 |
Nrip1 |
nuclear receptor interacting protein 1 |
437 |
0.87 |
chr13_81351343_81352153 | 2.17 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
122 |
0.98 |
chr18_80257995_80258304 | 2.16 |
Slc66a2 |
solute carrier family 66 member 2 |
1831 |
0.22 |
chr4_83050960_83052655 | 2.16 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
360 |
0.89 |
chr16_18430494_18430682 | 2.15 |
Txnrd2 |
thioredoxin reductase 2 |
1663 |
0.22 |
chr10_61977984_61979348 | 2.15 |
Col13a1 |
collagen, type XIII, alpha 1 |
407 |
0.84 |
chr16_18429039_18430122 | 2.14 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr2_32721862_32722483 | 2.14 |
Sh2d3c |
SH2 domain containing 3C |
1117 |
0.24 |
chr14_121355383_121355958 | 2.14 |
Stk24 |
serine/threonine kinase 24 |
4198 |
0.25 |
chr3_65953043_65954518 | 2.13 |
Ccnl1 |
cyclin L1 |
787 |
0.49 |
chr2_164438272_164438997 | 2.12 |
Sdc4 |
syndecan 4 |
4552 |
0.1 |
chr7_132776252_132776889 | 2.12 |
Fam53b |
family with sequence similarity 53, member B |
346 |
0.89 |
chr4_40850475_40851213 | 2.11 |
Gm25931 |
predicted gene, 25931 |
442 |
0.43 |
chr11_106714520_106715257 | 2.10 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
58 |
0.97 |
chr6_34598108_34599085 | 2.08 |
Cald1 |
caldesmon 1 |
24 |
0.98 |
chr3_122247075_122247647 | 2.08 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
1280 |
0.26 |
chr9_50692780_50693781 | 2.07 |
Dixdc1 |
DIX domain containing 1 |
519 |
0.7 |
chr17_48271857_48272276 | 2.07 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
373 |
0.79 |
chrX_169037778_169038469 | 2.07 |
Arhgap6 |
Rho GTPase activating protein 6 |
1512 |
0.52 |
chr14_101841859_101842332 | 2.06 |
Lmo7 |
LIM domain only 7 |
1276 |
0.57 |
chr11_82989819_82989980 | 2.05 |
Slfn9 |
schlafen 9 |
1238 |
0.22 |
chr3_51377993_51378402 | 2.03 |
Gm5103 |
predicted gene 5103 |
121 |
0.93 |
chr4_102571547_102571702 | 2.03 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1529 |
0.55 |
chr4_129462538_129462888 | 2.01 |
Bsdc1 |
BSD domain containing 1 |
877 |
0.4 |
chr11_79522322_79522715 | 2.00 |
Evi2b |
ecotropic viral integration site 2b |
1244 |
0.3 |
chr11_116782685_116783105 | 2.00 |
St6galnac1 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
7388 |
0.12 |
chr13_97066853_97067365 | 2.00 |
Fam169a |
family with sequence similarity 169, member A |
177 |
0.94 |
chr2_72203811_72204385 | 2.00 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
5299 |
0.2 |
chr12_32123180_32123577 | 1.99 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
324 |
0.89 |
chr1_132379524_132380493 | 1.98 |
Gm15849 |
predicted gene 15849 |
1121 |
0.39 |
chr18_41860653_41861741 | 1.98 |
Gm50410 |
predicted gene, 50410 |
13637 |
0.22 |
chr1_130547972_130548539 | 1.97 |
Gm23623 |
predicted gene, 23623 |
47421 |
0.09 |
chr1_45924247_45924747 | 1.96 |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
765 |
0.56 |
chr3_146700203_146700695 | 1.95 |
Gm9480 |
predicted gene 9480 |
4230 |
0.17 |
chr16_58672078_58672766 | 1.95 |
Cpox |
coproporphyrinogen oxidase |
1714 |
0.26 |
chr9_84113968_84114740 | 1.94 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
6847 |
0.26 |
chr5_74064229_74066220 | 1.94 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr6_135362982_135365483 | 1.94 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr3_89136417_89137539 | 1.93 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr10_97481185_97481829 | 1.93 |
Dcn |
decorin |
860 |
0.67 |
chr3_130131738_130132096 | 1.92 |
Col25a1 |
collagen, type XXV, alpha 1 |
416 |
0.82 |
chr7_19290671_19291896 | 1.91 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr10_68135346_68136945 | 1.91 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
481 |
0.87 |
chr2_163641826_163642055 | 1.90 |
0610039K10Rik |
RIKEN cDNA 0610039K10 gene |
2910 |
0.17 |
chr5_143819795_143820265 | 1.90 |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
2083 |
0.28 |
chr3_131364286_131365636 | 1.90 |
Gm43116 |
predicted gene 43116 |
4405 |
0.21 |
chr1_51288641_51290950 | 1.89 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr16_22854094_22854317 | 1.87 |
Tbccd1 |
TBCC domain containing 1 |
2660 |
0.18 |
chr1_140181332_140181601 | 1.87 |
Cfh |
complement component factor h |
1814 |
0.43 |
chr19_29066961_29067664 | 1.87 |
Gm9895 |
predicted gene 9895 |
35 |
0.96 |
chr4_46400544_46400900 | 1.86 |
Hemgn |
hemogen |
3514 |
0.16 |
chr6_56902400_56902551 | 1.86 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
589 |
0.65 |
chr2_60939895_60940920 | 1.86 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22785 |
0.21 |
chr2_60672831_60673749 | 1.86 |
Itgb6 |
integrin beta 6 |
403 |
0.88 |
chr17_75435976_75437284 | 1.85 |
Rasgrp3 |
RAS, guanyl releasing protein 3 |
704 |
0.77 |
chr2_103960122_103960299 | 1.85 |
Lmo2 |
LIM domain only 2 |
2215 |
0.24 |
chr12_109455257_109457986 | 1.85 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
2426 |
0.16 |
chr9_70680771_70681491 | 1.85 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
2115 |
0.3 |
chr5_72224662_72225245 | 1.85 |
Atp10d |
ATPase, class V, type 10D |
21600 |
0.17 |
chr6_4506970_4507670 | 1.84 |
Gm43921 |
predicted gene, 43921 |
1233 |
0.34 |
chr1_34120973_34122005 | 1.84 |
Dst |
dystonin |
239 |
0.92 |
chr14_46761470_46761705 | 1.84 |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
992 |
0.38 |
chrX_75415065_75415623 | 1.84 |
Mtcp1 |
mature T cell proliferation 1 |
1074 |
0.25 |
chr18_80169288_80170029 | 1.83 |
Gm7447 |
predicted gene 7447 |
6906 |
0.09 |
chr18_75384437_75388058 | 1.83 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr1_156037391_156037734 | 1.82 |
Tor1aip1 |
torsin A interacting protein 1 |
1082 |
0.37 |
chr14_61649761_61650032 | 1.82 |
Gm27017 |
predicted gene, 27017 |
946 |
0.28 |
chr14_63164156_63165244 | 1.82 |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
225 |
0.91 |
chr11_83852457_83853638 | 1.82 |
Hnf1b |
HNF1 homeobox B |
87 |
0.96 |
chr11_97434598_97436859 | 1.81 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr11_61686479_61686890 | 1.81 |
Fam83g |
family with sequence similarity 83, member G |
2265 |
0.26 |
chr5_74197172_74198949 | 1.80 |
Rasl11b |
RAS-like, family 11, member B |
169 |
0.94 |
chr5_53564312_53564803 | 1.80 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
8723 |
0.2 |
chr3_65954778_65955426 | 1.79 |
Ccnl1 |
cyclin L1 |
1754 |
0.22 |
chr12_77059916_77060880 | 1.79 |
Gm35189 |
predicted gene, 35189 |
18197 |
0.2 |
chr3_137980299_137981827 | 1.79 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
467 |
0.74 |
chr15_81104326_81105439 | 1.78 |
Mrtfa |
myocardin related transcription factor A |
201 |
0.93 |
chr5_121233582_121234161 | 1.77 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
13652 |
0.13 |
chr7_134222911_134223711 | 1.77 |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
1786 |
0.37 |
chr18_39484877_39485553 | 1.77 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
2017 |
0.42 |
chrX_9273740_9273937 | 1.76 |
Xk |
X-linked Kx blood group |
1082 |
0.4 |
chr6_136855871_136856717 | 1.75 |
Art4 |
ADP-ribosyltransferase 4 |
1439 |
0.23 |
chr12_80113642_80114602 | 1.75 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
1109 |
0.34 |
chrX_8073345_8073663 | 1.75 |
Suv39h1 |
suppressor of variegation 3-9 1 |
754 |
0.39 |
chr9_21962987_21963138 | 1.75 |
Epor |
erythropoietin receptor |
444 |
0.65 |
chr14_65806618_65806896 | 1.75 |
Pbk |
PDZ binding kinase |
525 |
0.78 |
chr2_28619027_28619457 | 1.75 |
Gfi1b |
growth factor independent 1B |
2703 |
0.16 |
chr10_51526470_51526913 | 1.74 |
Gm46224 |
predicted gene, 46224 |
351 |
0.76 |
chr3_135607346_135607932 | 1.74 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
631 |
0.72 |
chr17_48281358_48282142 | 1.74 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
9311 |
0.12 |
chr1_133492302_133493599 | 1.73 |
Gm8596 |
predicted gene 8596 |
36529 |
0.14 |
chr9_113969212_113969700 | 1.73 |
Ubp1 |
upstream binding protein 1 |
231 |
0.9 |
chr9_92251154_92251727 | 1.73 |
Plscr1 |
phospholipid scramblase 1 |
1098 |
0.45 |
chr3_146047158_146048273 | 1.73 |
Wdr63 |
WD repeat domain 63 |
530 |
0.75 |
chr13_51647699_51648388 | 1.73 |
Gm22806 |
predicted gene, 22806 |
156 |
0.94 |
chr5_150207410_150208202 | 1.73 |
Fry |
FRY microtubule binding protein |
11340 |
0.2 |
chr1_66838249_66838716 | 1.73 |
Gm15793 |
predicted gene 15793 |
11120 |
0.08 |
chr2_173024069_173026002 | 1.72 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr11_6295096_6295368 | 1.72 |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
2627 |
0.17 |
chr11_32293730_32294350 | 1.72 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
2449 |
0.16 |
chr1_87573319_87573846 | 1.72 |
Ngef |
neuronal guanine nucleotide exchange factor |
288 |
0.62 |
chr9_78104831_78105183 | 1.72 |
Fbxo9 |
f-box protein 9 |
3580 |
0.15 |
chr1_9798833_9798989 | 1.72 |
Sgk3 |
serum/glucocorticoid regulated kinase 3 |
703 |
0.58 |
chr1_80708717_80710377 | 1.72 |
Dock10 |
dedicator of cytokinesis 10 |
51 |
0.98 |
chr3_87767082_87768667 | 1.72 |
Pear1 |
platelet endothelial aggregation receptor 1 |
1061 |
0.43 |
chr14_79296497_79296648 | 1.71 |
Rgcc |
regulator of cell cycle |
5073 |
0.19 |
chr19_55926597_55927105 | 1.71 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
28542 |
0.21 |
chr6_34599135_34600037 | 1.71 |
Cald1 |
caldesmon 1 |
966 |
0.58 |
chr16_49857400_49857908 | 1.71 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
1867 |
0.46 |
chr1_160308144_160309427 | 1.71 |
Rabgap1l |
RAB GTPase activating protein 1-like |
386 |
0.8 |
chr5_67815409_67815775 | 1.70 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
261 |
0.89 |
chr7_103824785_103825302 | 1.70 |
Hbb-bs |
hemoglobin, beta adult s chain |
2682 |
0.09 |
chr7_35121809_35121960 | 1.70 |
Gm45091 |
predicted gene 45091 |
2279 |
0.15 |
chr15_58594635_58595816 | 1.69 |
Fer1l6 |
fer-1-like 6 (C. elegans) |
43280 |
0.17 |
chr3_137341050_137342448 | 1.69 |
Emcn |
endomucin |
575 |
0.82 |
chr6_99094571_99094983 | 1.69 |
Foxp1 |
forkhead box P1 |
1428 |
0.5 |
chr11_83285353_83286025 | 1.69 |
Slfn14 |
schlafen 14 |
1037 |
0.31 |
chr10_122794250_122795006 | 1.68 |
Gm36208 |
predicted gene, 36208 |
2145 |
0.27 |
chr5_52254526_52255173 | 1.68 |
Gm43180 |
predicted gene 43180 |
15513 |
0.15 |
chrX_85613609_85614890 | 1.68 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chrX_75129536_75129742 | 1.68 |
Mpp1 |
membrane protein, palmitoylated |
1205 |
0.3 |
chr3_14891263_14891907 | 1.67 |
Car2 |
carbonic anhydrase 2 |
4946 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 7.6 | GO:0003166 | bundle of His development(GO:0003166) |
1.9 | 1.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.6 | 4.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.4 | 4.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.3 | 5.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.2 | 3.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 3.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 5.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.0 | 4.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.0 | 2.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.0 | 2.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.0 | 3.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.9 | 4.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 2.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.9 | 2.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 0.9 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.9 | 2.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 2.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.8 | 2.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.8 | 2.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.8 | 3.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.8 | 3.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.8 | 3.2 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 3.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 2.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.8 | 3.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 4.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 2.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.7 | 2.7 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 2.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 1.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 1.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 3.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.6 | 1.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 1.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.6 | 1.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 1.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.6 | 1.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.6 | 0.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.6 | 1.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 1.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.6 | 1.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.6 | 1.8 | GO:0042117 | monocyte activation(GO:0042117) |
0.6 | 1.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 0.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 2.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 1.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 4.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 1.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.6 | 1.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 1.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 1.6 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 1.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 2.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.5 | 1.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.5 | 0.5 | GO:0007494 | midgut development(GO:0007494) |
0.5 | 3.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 2.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 1.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 0.5 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.5 | 2.0 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.5 | 1.0 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 0.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.5 | 1.0 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 1.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 4.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 2.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 10.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 2.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 2.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.9 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 1.0 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 0.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.5 | 1.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.5 | 0.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 0.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.5 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 6.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 0.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.5 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 1.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 0.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.5 | 1.4 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.5 | 5.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 1.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 0.4 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.4 | 1.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.4 | 2.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 0.4 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.4 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 1.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 2.2 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.4 | 2.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 1.3 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.4 | 2.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 1.7 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 2.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.4 | 1.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.4 | 1.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 0.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 1.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 3.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 1.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 1.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 2.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 0.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 2.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 2.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 2.4 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 1.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 0.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 2.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 1.2 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.4 | 0.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.4 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 0.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 1.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 2.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 1.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 0.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 0.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 2.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 2.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 1.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 1.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 0.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 2.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 0.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 0.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 1.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 0.4 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.4 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 0.7 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 2.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 1.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.4 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 0.4 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.4 | 1.4 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.4 | 1.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 1.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 1.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 1.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.3 | 1.4 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.7 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 1.0 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.3 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 2.1 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 1.4 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 0.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 1.0 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.3 | 2.4 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.3 | 2.7 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 1.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.3 | 0.7 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.7 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 1.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 1.9 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 1.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 0.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.3 | 1.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 0.9 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.3 | 1.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 2.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 2.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 0.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 1.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 1.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 2.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 2.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 2.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.3 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 0.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.3 | 1.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.3 | 2.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 2.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 1.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.9 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 3.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 8.0 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.3 | 0.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 2.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.3 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 0.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 0.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 1.7 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 1.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.3 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 2.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.3 | 1.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 0.6 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.3 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.1 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.3 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 2.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.3 | 2.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.3 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.3 | 1.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.8 | GO:0060430 | lung saccule development(GO:0060430) |
0.3 | 1.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 1.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.3 | 0.5 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.3 | 4.3 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.3 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 2.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 1.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.8 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 0.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 0.3 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.3 | 1.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 3.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.8 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.3 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 3.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 2.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 2.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 1.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.8 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.5 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 2.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 1.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 2.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.3 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.3 | 0.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.5 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.3 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 2.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 1.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 1.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.7 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 0.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 1.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 3.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 1.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 1.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 1.9 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 2.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 3.8 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 2.6 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 2.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.5 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 1.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.2 | 4.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 2.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.2 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 2.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 3.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.5 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.2 | 1.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 0.5 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.2 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.2 | 0.2 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.2 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.2 | 0.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 1.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 4.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 1.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.2 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 1.8 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 0.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.2 | 1.8 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 4.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 2.2 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.2 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.2 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 3.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 5.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 2.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 1.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.9 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.2 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.2 | GO:0031860 | telomeric loop formation(GO:0031627) telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 1.5 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.2 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 0.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 1.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.8 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 1.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 2.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 0.2 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 6.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.4 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 1.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 1.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.6 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 1.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.6 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.8 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 5.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 3.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 1.9 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 1.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 1.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.4 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 1.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 2.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 1.3 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.4 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.2 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.4 | GO:0042119 | neutrophil activation involved in immune response(GO:0002283) neutrophil activation(GO:0042119) neutrophil degranulation(GO:0043312) |
0.2 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 1.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.6 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 3.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 1.3 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.2 | 2.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.7 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 1.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.4 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 3.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.5 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.5 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.2 | 1.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.2 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 1.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.4 | GO:0051029 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.2 | 0.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.4 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 4.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 1.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 0.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 1.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 2.0 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.2 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 1.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 1.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 2.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 2.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.2 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.5 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 0.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 1.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.5 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 2.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.2 | 0.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.3 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) chemokine metabolic process(GO:0050755) |
0.2 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.2 | 1.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 1.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 2.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.2 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.9 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 2.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.6 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 2.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.1 | GO:0097503 | sialylation(GO:0097503) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.7 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 2.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 2.5 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.1 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 3.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.7 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 3.3 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 2.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.4 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.3 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.7 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 1.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 1.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 1.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.4 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.7 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 3.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 2.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.4 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 1.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.8 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 4.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.5 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.1 | 1.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.2 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.6 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 3.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.9 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 3.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 1.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 3.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 1.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 2.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 1.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.8 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.7 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 1.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.4 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.2 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.4 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.7 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 1.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 4.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 1.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 2.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 1.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 2.6 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.5 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 1.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 2.9 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.4 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 2.2 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 1.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 1.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.7 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 1.5 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 1.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 2.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 2.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 1.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 1.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.6 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.6 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 2.9 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 1.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.1 | 1.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 2.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 2.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 1.4 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 2.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.4 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 1.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 1.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 2.4 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.3 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.6 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) positive regulation of lymphocyte differentiation(GO:0045621) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.6 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 2.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 3.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 2.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 1.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 1.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.1 | 0.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 1.9 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.1 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.9 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.1 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 6.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 2.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.1 | 2.8 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.5 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 1.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.1 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.0 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 1.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0001660 | fever generation(GO:0001660) regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.2 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 1.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.4 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 2.5 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0016233 | telomere capping(GO:0016233) |
0.1 | 0.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.1 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.9 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 1.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 0.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 1.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.4 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.0 | 0.0 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.0 | 0.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 1.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.4 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.0 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.0 | 0.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.4 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.0 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.3 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 3.0 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 1.5 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.8 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.0 | 0.0 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.0 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.8 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.0 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.3 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.1 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 1.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 1.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.0 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.0 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.4 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 1.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.4 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 2.9 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.9 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0006639 | acylglycerol metabolic process(GO:0006639) |
0.0 | 0.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.1 | GO:0006497 | protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.0 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.0 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 2.0 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.0 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.0 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.0 | 0.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.0 | 0.0 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 3.9 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 2.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 0.8 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.7 | 3.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.6 | 3.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 2.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 0.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 1.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 2.9 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 3.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 3.1 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 3.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 4.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.5 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 1.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 1.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 1.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 2.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 1.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 7.9 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 4.5 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 3.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 1.6 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 2.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 2.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.4 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 2.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 1.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 4.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 1.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 2.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 2.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 1.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.2 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 3.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 0.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 2.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.6 | GO:0005818 | aster(GO:0005818) |
0.3 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 1.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 3.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.5 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 1.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 2.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.7 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 7.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 2.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 3.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 3.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 2.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 2.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 3.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 7.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 6.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 1.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 1.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 2.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 2.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 11.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 2.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 1.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 3.9 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 5.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 1.2 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 3.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 1.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 4.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 2.2 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 6.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 2.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 2.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 6.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 11.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 2.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.5 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.0 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 6.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 1.4 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 5.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 8.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 2.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 3.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 2.4 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 1.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 1.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 4.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 9.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 6.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 4.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 6.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 2.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 26.0 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.9 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 4.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 1.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.1 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 3.7 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 3.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 16.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.7 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 4.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 2.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 4.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 21.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 4.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 2.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 2.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 5.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 8.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 14.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.2 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.4 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 3.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 3.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 5.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 2.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.6 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 3.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.8 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.5 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 49.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.5 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 1.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 64.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 4.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 5.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.1 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.8 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 2.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 18.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0044450 | centriolar satellite(GO:0034451) microtubule organizing center part(GO:0044450) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 8.6 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 1.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
1.0 | 4.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.0 | 3.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.0 | 5.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.0 | 3.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 3.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.8 | 1.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.7 | 4.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 2.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 3.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.6 | 1.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 1.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 3.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.5 | 4.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 2.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 0.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.5 | 1.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 1.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 2.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 6.5 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 1.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 1.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 7.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 1.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 2.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 1.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 4.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 2.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 1.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 1.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 2.2 | GO:0034805 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 2.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 1.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 4.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 2.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 4.4 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 1.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 1.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 2.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 1.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 2.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 0.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 4.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 0.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 0.3 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 3.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 2.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 2.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 1.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 1.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 0.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 4.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 1.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.3 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 0.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 2.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 6.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 2.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 4.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.8 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 1.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 2.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 2.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 4.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 1.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.7 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 2.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 2.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 1.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 2.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 5.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 11.1 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 2.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 2.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 4.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 1.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 1.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 3.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 4.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 4.1 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 2.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 2.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 4.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 2.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 0.4 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 3.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 7.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 4.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 2.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 3.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.5 | GO:0080084 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.7 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.2 | 0.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 3.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 2.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.0 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 3.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 11.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 3.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 2.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.5 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 1.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.5 | GO:0043141 | 5'-3' DNA helicase activity(GO:0043139) ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.2 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 3.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.0 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.5 | GO:0051379 | epinephrine binding(GO:0051379) |
0.2 | 0.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 4.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 2.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 2.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 11.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 2.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 6.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 3.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 2.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 4.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 2.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.1 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.0 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 2.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 3.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 3.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 6.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 7.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.1 | 4.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 1.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.3 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 3.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 2.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.1 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 4.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 5.3 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 2.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 6.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 2.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 2.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 2.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 3.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.1 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 2.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 2.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.6 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 15.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 6.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 1.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0034416 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 1.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 1.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 3.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 8.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 8.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 11.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 2.0 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.3 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 2.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 1.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 4.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 1.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 2.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 7.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 2.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.5 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 4.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 1.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 2.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 4.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 1.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.3 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 1.6 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.0 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 2.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.3 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 1.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.9 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 1.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 1.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.0 | 2.2 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.0 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.0 | 2.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 2.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.2 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.4 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 5.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 6.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 4.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 12.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 17.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 3.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 14.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 14.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 12.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 8.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 7.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 6.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 7.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 5.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.2 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 5.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 3.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 7.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 5.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 7.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 10.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 3.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 4.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 3.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 4.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 3.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 7.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 3.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 11.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 11.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 2.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 2.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 9.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 4.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 3.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 0.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 2.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 2.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 8.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 4.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 0.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 5.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 3.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 4.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 0.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 7.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 2.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 0.9 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.3 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 7.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 6.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 2.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 7.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 4.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 2.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 4.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 2.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 3.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 5.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 4.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 4.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 4.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 3.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 4.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 4.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 2.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 5.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 3.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 11.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 9.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 9.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 12.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 4.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 5.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 8.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 1.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 4.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.1 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 6.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 1.0 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 8.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 5.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 7.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 7.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 1.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 4.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 2.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 2.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 11.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 3.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 4.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 4.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 8.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 6.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 10.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 5.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 5.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 2.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.1 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 4.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 1.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 4.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.1 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |